• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA SRL PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA SRL PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS25
Device Problem Insufficient Information (3190)
Patient Problem Endocarditis (1834)
Event Date 06/01/2016
Event Type  malfunction  
Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Since the device remains implanted, no further investigation is possible at this time.Based on the available information, the root cause of the reported event cannot be definitively stated.However, based on the document review performed, no manufacturing nor quality deficits were identified.Endocarditis is listed as a possible adverse event in the perceval instructions for use (ifu).The event is, therefore, a known inherent risk of the device.The manufacturer has requested additional information on this event.Should further information be received, an update to this reporting activity will be provided.Device still implanted.
 
Event Description
The manufacturer was informed on this event through the sure avr registry.On (b)(4) 2013, a patient received a pvs25 in aortic position.The procedure occurred in mini sternotomy and no concomitant procedures were performed.A good valve functionality was detected at discharge and at 1 year follow up ((b)(6)2014).The manufacturer was informed that on (b)(6) 2016 the patient had valve endocarditis, primary onset and microorganism unknown.There is no indication of treatment or re-intervention on the database.
 
Manufacturer Narrative
Based on the additional information received, the device remains implanted with a good outcome after the targeted antibiotic therapy.Given the late occurrence of endocarditis after implant, and confirmation from the site that the origin seems to be linked to cholecystitis (for which the patient was operated again in (b)(6) 2018), it is reasonable to conclude that the root cause of the reported event was related to patient factors, and not related to the device.
 
Event Description
Per additional information received, the manufacturer was informed that no new surgery was performed but the endocarditis was treated conservatively with targeted antibiotic therapy with subsequent healing.As reported, the pathogen is unknown because the hospitalization took place in another hospital, but the origin seems to be linked to cholecystitis.No echocardiographic findings relating to the prosthesis is available but a subsequent well-being was reported after the episode.The patient had a favorable outcome after the event and was in full well-being until (b)(6) 2018 when he underwent a gallbladder removal surgery for gangrenous cholecystitis with peritonitis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
SORIN GROUP ITALIA SRL
strada crescentino snc
saluggia, vercelli
MDR Report Key11025050
MDR Text Key244002451
Report Number3005687633-2020-00154
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup
Report Date 01/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/09/2016
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/17/2020
Initial Date FDA Received12/17/2020
Supplement Dates Manufacturer Received12/18/2020
Supplement Dates FDA Received01/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age84 YR
Patient Weight69
-
-